Top searches

PL

Resources

B2RLaw advises biotech company Ambulero on fundraising

27/01/2021

B2RLaw has advised Ambulero, Inc., a biotechnology company developing cell and gene therapy treatments for patients suffering from vascular disease on funding of up to USD 5.5 million received from from Orphinic Scientific.

As part of the investment, and with the help of B2RLaw, Ambulero and Orphinic formed a Polish subsidiary (Ambulero Sp. z o.o.) that will lead clinical testing of a novel gene therapy for a serious vascular disease in Europe. The disease is rare in the US but more common in certain parts of Central and Eastern Europe.

Ambulero is a biotechnology company dedicated to advancing a platform of cell and gene therapies to treat serious vascular diseases. The company is a 2019 spin-out of the University of Miami co-founded by Robert L. Buchanan, Randy Berholtz, Omaida C. Velazquez and Jun Zhao-Liu. It holds an exclusive license from the University of Miami to develop and commercialize research from the laboratories of Drs. Omaida C. Velazquez and Jun Zhao-Liu.

With offices in Palo Alto, California and Warsaw, Poland, Orphinic Scientific is an innovative drug development and investment company focused on mid-market opportunities and orphan drugs in late preclinical research and Phase 1 or 2.

B2RLaw’s team was led by Partner Szymon Syp and included Senior Associate Iga Wojtczak – Opala and Junior Associate Jakub Niemiec.

Szymon Syp advises, “We congratulate Ambulero and Orphinic Scientific on this transaction. Ambulero’s important work means that people that suffer from serious vascular disease (which at best, causes severe discomfort and at worst, can result in death) can live in comfort with the knowledge that innovative treatment is on the horizon. We wish Ambulero the best of luck on its future clinical testing”.

View more resources

Catch up on the very latest B2RLAW
announcements and news here.

27/08/2021

B2RLaw advises early stage technology company The Village Network on financing received by Movens Capital

B2RLaw has advised The Village Network, a Polish company creating Wioski.co, which is run by three female entrepreneurs, and supports […]

MORE
11/08/2021

B2RLaw further strengthens Real Estate Practice to create all-star team

B2RLaw has appointed Andrzej Zając as Counsel to its Real Estate Practice. Andrzej is a next generation leader with a […]

MORE
24/06/2021

B2RLaw advises Kennet Partners and Digital+ Partners on their USD 30 million equity investment in eStoreMedia

B2RLaw has advised growth equity investors Kennet Partners and Digital+ Partners on their USD 30 million equity investment in Polish […]

MORE
14/06/2021

B2RLaw named Venture Capital Legal Advisor of the Year at the PSIK Awards 2021

B2RLaw is celebrating after being awarded Venture Capital Legal Advisor of the Year at the Polish Private Equity and Venture […]

MORE
09/06/2021

Edyta Zalewska joins B2RLaw’s Partnership, and six lawyers are promoted

B2RLaw has announced Edyta Zalewska as Partner in its 2021 promotion round, effective as of 1st May 2021. B2RLaw is also […]

MORE
11/05/2021

B2RLaw shortlisted as a finalist of the PSIK Awards 2021 for Venture Capital Legal Advisor of the Year

B2RLaw is pleased to advise that it has been selected as a finalist of the PSIK Awards 2021 for Venture […]

MORE

Get in touch

Not sure who to contact? Let us help you find the right lawyer.

This site uses cookies to improve your experience More information.

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close